Indaptus Accounts Payable vs Net Working Capital Analysis
| INDP Stock | USD 1.13 0.05 4.24% |
Indaptus Therapeutics financial indicator trend analysis is infinitely more than just investigating Indaptus Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Indaptus Therapeutics is a good investment. Please check the relationship between Indaptus Therapeutics Accounts Payable and its Net Working Capital accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
Accounts Payable vs Net Working Capital
Accounts Payable vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Indaptus Therapeutics Accounts Payable account and Net Working Capital. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Indaptus Therapeutics' Accounts Payable and Net Working Capital is -0.46. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Indaptus Therapeutics, assuming nothing else is changed. The correlation between historical values of Indaptus Therapeutics' Accounts Payable and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Indaptus Therapeutics are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Accounts Payable i.e., Indaptus Therapeutics' Accounts Payable and Net Working Capital go up and down completely randomly.
Correlation Coefficient | -0.46 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents Indaptus Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Indaptus Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Net Working Capital
Most indicators from Indaptus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.As of 11/14/2024, Selling General Administrative is likely to drop to about 5.3 M. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 17.7K | 588.1K | 676.3K | 710.1K | Depreciation And Amortization | 1.4K | 1.8K | 1.3K | 1.2K |
Indaptus Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Indaptus Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Indaptus Stock
Moving against Indaptus Stock
| 0.62 | VERA | Vera Therapeutics | PairCorr |
| 0.57 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.55 | DNLI | Denali Therapeutics | PairCorr |
| 0.51 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.